Siga Technologies @SigaTech Twitter profile

Last Seen Profiles

@DaJuice2121

@LAZoo

@Kold_Wave

@Llama_Train_S

@jandakembangstw

@Hyperoptic

@elliottbaseball

@SectorZeroHQ

@ShaweeshAbed

@AnakRan97607224

@tsubasaE3

@BhamSENDinfo

@AnakRan97607224

@monaauraa

@bokeplokalmalam

@himelissahunter

@CarmackNic20651

@Mxgan_Jxne

@KlaireOnyeka

@tomoruri_1225

@kyoukoufks

@himelissahunter

@Dino09304353

@gabriellll_15

@ria0537

@stwmaniax

@KSawwarsawwar

@DByamanori

@Babpjj__

@AnakRan97607224

@nu_carnivalUKR

@2imbloom

@stw_pdg

@Livai333

@SammyHareBall

Siga Technologies

@SigaTech

2 years

Medical experts including @drsanjaygupta from @cnn are focusing on the treatment of monkeypox with patients who are willing to share their stories. You can see Dr. Gupta’s story here: .

7

9

35

Siga Technologies

@SigaTech

2 years

SIGA announces approx $13M of procurement orders for oral TPOXX, including $11M for initial procurement from two new international jurisdictions & approximate $2M from a country in the Asia Pacific region, in response to monkeypox outbreak. To learn more:

2

4

31

Siga Technologies

@SigaTech

2 years

The UK has approved SIGA’s oral tecovirimat (TPOXX) for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in adults and children with a body weight of at least 13kg. For more please visit:

SIGA Technologies Receives Approval from UK for Tecovirimat

Treatment Approved for Smallpox, Monkeypox, Cowpox, and Vaccinia Complications...

www.globenewswire.com

0

5

27

Siga Technologies

@SigaTech

2 years

Findings published in the @TheLancetInfDis on treatment of monkeypox patients in the UK: Patient treated with tecovirimat experienced no adverse effects. TPOXX (Tecovirimat) is approved in the US for smallpox and in the European Union for smallpox/monkeypox/cowpox and

5

4

28

Siga Technologies

@SigaTech

2 years

As smallpox immunity wanes, SIGA technologies addresses the issue of orthopox virus antivirals and treatments with our proposed solution, TPOXX. To learn more watch:

SIGA Technologies – executive interview

SIGA Technologies (Nasdaq: SIGA) is a commercial-stage company focusing on health security. Its lead program is oral TPOXX (tecovirimat), which was approved ...

www.youtube.com

3

5

25

Siga Technologies

@SigaTech

2 years

The @CDCgov has provided guidance for Tecovirimat use under expanded investigational new drug protocol for monkeypox treatment. For more information visit:

9

6

22

Siga Technologies

@SigaTech

2 years

With monkeypox cases rising & interest in access to treatment increasing, we’ve received questions about how TPOXX was approved by regulatory agencies in Europe, UK & US. @NJEM video summarizes 2018 data supporting the approvals in Europe and the UK.

Treating Smallpox

Smallpox was declared eradicated in 1980, but variola virus, which causes smallpox, still exists, and there is no known effective treatment. Full study: http...

www.youtube.com

5

4

21

Siga Technologies

@SigaTech

2 years

Please join us tomorrow at 12pm EST for A.G.P.’s Monkeypox panel. SIGA will be presenting alongside Emergent Biosolutions & TONIX Pharmaceuticals to discuss the recent outbreaks of monkeypox in the U.K., EU, & U.S. For more information & to register:

SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022

SIGA to Appear alongside Emergent Biosolutions and Tonix Pharmaceuticals...

www.globenewswire.com

3

4

20

Siga Technologies

@SigaTech

9 months

In an era marked by significant advances in biological sciences, there are also concerns about the development of biological weapons. This @BelferCenter article outlines current U.S government processes to bolster #biosecurity measures. See here:

Modernizing Biosecurity and Biosafety in the U.S.: Key Lessons Learned

www.belfercenter.org

5

2

Siga Technologies

@SigaTech

2 years

SIGA’s CSO was interviewed regarding the monkeypox outbreaks in the US and Europe. Full details here:

This monkeypox antiviral drug may soon be in high demand

Shares in companies that make antiviral drugs to fight smallpox and related viruses have soared as monkeypox cases multiply in Europe and North America.

www.euronews.com

2

17

Siga Technologies

@SigaTech

2 years

Today at 4:30 EST, the SIGA team will be hosting our Q2 2022 earnings call. For information on how to join via telephone or webcast, please visit:

15

3

16

Siga Technologies

@SigaTech

3 years

“Somebody would reconstruct, say, a smallpox virus and have that spread, and that would not only kill millions, it could potentially kill billions” – Bill Gates on bioterrorism, 2017, PBS

4

15

Siga Technologies

@SigaTech

2 years

SIGA is pleased to announce it has received @US_FDA approval for the intravenous (IV) formulation of TPOXX for the treatment of smallpox. This provides an important option for those unable to take the oral formulation of the drug. Full details here:

2

5

13

Siga Technologies

@SigaTech

2 years

Ben Novak, SIGA’s Director of Business Development, will present Wed at 8:30 AM CET at NCT Europe 2022; ‘Medical Preparedness for CBRNe Events’ covers the importance of availability of treatments in the face of potential threats. More from @IBConsultancy :

2

13

Siga Technologies

@SigaTech

2 years

@SIGA is excited to announce a collaboration with @KaliVir to make TPOXX available to support future clinical programs of KaliVir’s oncolytic vaccinia immunotherapy platform. For more information:

2

4

14

Siga Technologies

@SigaTech

2 years

What is happening in Africa will definitely impact what is happening in the West and vice versa.” Says Yap Boum, an epidemiologist in Cameroon who works with Doctors Without Borders. To learn more about monkeypox and its impacts see @ScienceMagazine :

Monkeypox is a new global threat. African scientists know what the world is up against

Cases in West and Central Africa have been on the rise for decades

www.science.org

4

2

11

Siga Technologies

@SigaTech

2 years

Last week @SIGA announced approximately $28 million of procurement orders for oral TPOXX. For the full story check:

3

1

12

Siga Technologies

@SigaTech

2 years

SIGA's TPOXX (tecovirimat) used to treat a Dallas monkeypox patient, @CDCgov reports: . TPOXX is US FDA-approved only for treatment of smallpox.

0

2

10

Siga Technologies

@SigaTech

2 years

In a study published on @NatureMicrobiol , in vitro analysis of the virus isolate of the first human monkeypox case in France shows that TPOXX (tecovirimat) is effective against the virus at nanomolar concentrations. To read the full study please visit:

Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations

Nature Microbiology - Tecovirimat blocks replication of 2022 monkeypox virus isolate in vitro, supporting its use in ongoing human clinical trials.

www.nature.com

1

0

9

Siga Technologies

@SigaTech

2 years

SIGA announced today the international procurement of roughly $16 million for oral TPOXX®, including approx. $10m from the European Commission and approx. $6m from two countries in the APAC region. For more details, see here:

10

0

10

Siga Technologies

@SigaTech

2 years

“We were developing a drug for a disease that doesn’t exist. It took a long time to figure out,” Dennis Hruby says as he speaks about SIGA’s story to the Wall Street Journal. To read the full article visit:

Monkeypox Antiviral Originated as Post-9/11 Bioterrorism Defense

SIGA has received $60 million in orders for Tpoxx, which was developed to treat smallpox in the event of an attack.

www.wsj.com

9

0

10

Siga Technologies

@SigaTech

2 years

complications from vaccinia.

0

1

8

Siga Technologies

@SigaTech

3 months

Today, we announced that the U.S. Department of Health and Human Services has exercised a procurement option for the delivery of approximately $113 million of oral TPOXX® treatment courses. See here:

0

1

7

Siga Technologies

@SigaTech

1 year

In this @ThinkGlobalHlth article, @HelenClarkNZ , @MaEllenSirleaf , @DMiliband , @DreJoanneLiu , @MauricioCard , and @Kazatchkine from @TheIndPanel explore how a Global Threats Health Council could support @WHO in extending #pandemic readiness:

Leadership Is Essential to End the Pandemic Panic | Think Global Health

The mission of a Global Health Threats Council extends beyond health

www.thinkglobalhealth.org

1

5

8

Siga Technologies

@SigaTech

1 year

Congrats to our CEO Phil Gomez for being named as one of the Top 25 Healthcare Technology Leaders of Washington, DC for 2023! We are proud of the work Dr. Gomez has done to help provide solutions for unmet needs in the #healthsecurity market. Learn more:

0

2

5

Siga Technologies

@SigaTech

2 years

We’re focused on enhancing preparedness against #smallpox . See our Special Report in Expert Review of Anti-infective Therapy, a @tandfonline journal, on the need for #antiviral treatments. Research was funded in part by @BARDA and @NIAIDNews #publichealth

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of...

Tecovirimat oral capsule formulation is approved in the US and Canada for treatment of smallpox and in the United Kingdom (UK) and European Union (EU) for treatment of multiple human orthopoxvirus ...

www.tandfonline.com

1

7

Siga Technologies

@SigaTech

2 years

Happy to announce that TPOXX has been featured on @TIME ’s Best Inventions of 2022 List. To read the full feature please visit:

Siga Technologies TPOXX (Tecovirimat): The 200 Best Inventions of 2022

Find out why Siga Technologies TPOXX (Tecovirimat) made this year's list

time.com

7

0

6

Siga Technologies

@SigaTech

2 months

The @WHO has declared #mpox a #publichealth emergency of international concern ( #PHEIC ), triggered by a major outbreak of the viral infection in the DRC and its expansion to nearby countries.

World Health Organization (WHO)

@WHO

2 months

@DrTedros "Today, the Emergency Committee met and advised me that in its view, the situation constitutes a public health emergency of international concern. I have accepted that advice"- @DrTedros #mpox

319

794

1K

4

1

5

Siga Technologies

@SigaTech

2 months

Listen to our Executive Vice President and Chief Medical Officer, @DrJayVarma , discuss the initial results from the PALM 007 clinical trial in this video:

18

4

5

Siga Technologies

@SigaTech

3 years

SIGA is pleased to announce that it has received approval from Health Canada for oral TPOXX as an extraordinary use new drug. This is a key milestone for SIGA’s partnership with @NationalDefence and will allow SIGA to continue to supply oral TPOXX to the DND and @GovCanHealth .

0

1

5

Siga Technologies

@SigaTech

9 months

In this @GoHealio article, #publichealth experts including our EVP and CMO, @DrJayVarma , share insights on preparedness for the next pandemic as part of the “Life during COVID” series. See here:

Is the US prepared for the next pandemic?

In September 2021, the Biden administration introduced the American Pandemic Preparedness Plan, a proposal to transform the country’s capabilities to respond to future pandemics.

www.healio.com

0

1

3

Siga Technologies

@SigaTech

2 years

We are honored to be recognized as one of @Forbes 2023 America’s Best Small Companies. This recognition is a tribute to our team and the impact we have made in providing solutions for unmet needs in the #healthsecurity market. To learn more, visit:

0

4

Siga Technologies

@SigaTech

1 month

Today we announced a new contract with the @DeptofDefense for the procurement of approximately $9 million of our antiviral drug, representing the third procurement contract award from the DOD in the past three years. See our press release:

4

1

5

Siga Technologies

@SigaTech

2 years

Throughout the monkeypox outbreak @SIGA has received TPOXX orders from more than 13 entities across the world including the U.S. To learn more about the most recent $10.7M order from the U.S. Department of Defense please visit:

Siga Tech receives $10.7-mln order for antiviral Tpoxx amid monkeypox outbreak

Siga Technologies said on Thursday it has won a new contract for its oral antiviral drug, Tpoxx, worth up to $10.7 million from the U.S. Department of Defense as the country stocks up on the treatm...

www.reuters.com

8

2

4

Siga Technologies

@SigaTech

7 months

#Smallpox and other orthopoxviruses pose significant threats to the world and are capable of deliberate weaponization, accidental release, & exploitation of vulnerable populations. Read more in the @BioCommission ’s recent report: #BoxthePox

0

2

5

Siga Technologies

@SigaTech

2 years

Today SIGA announced financial results for the third quarter of 2022. To read the full release and join the earnings call at 4:30 today, visit:

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022

- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03,...

www.globenewswire.com

2

1

5

Siga Technologies

@SigaTech

10 months

Earlier this month, our EVP and CMO, @DrJayVarma provided his insights about pandemic preparedness and #biodefense policies at the @BioCommission meeting. View Dr. Varma's testimony:

1

4

Siga Technologies

@SigaTech

1 year

Our Executive Vice President and Chief Scientific Officer Dr. Dennis Hruby participated in a Q&A with @ClinicalLeader1 to discuss our focus on medical countermeasures for #CBRN threats and emerging #infectiousdiseases . Read the full article:

Securing FDA Expanded Access Designation For An Emergent Public Need

In this Q&A, SIGA Technologies Executive Vice President and Chief Scientific Officer Dennis Hruby discusses the journey toward expanded access, or compassionate use, of TPOXX and the importance of...

www.clinicalleader.com

0

3

Siga Technologies

@SigaTech

1 year

A recent study conducted by @LancetGH describes the main epidemiological features of the #mpox outbreak, presents new and evolving features of this #infectiousdisease , and highlights differences in regional trends. See here:

Description of the first global outbreak of mpox: an analysis of global surveillance data

Continued global surveillance allowed WHO to monitor the epidemic, identify risk factors, and inform the public health response. The outbreak can be attributed to clade IIb MPXV spread by newly...

www.thelancet.com

0

2

4

Siga Technologies

@SigaTech

1 year

As cases are increasing in other countries, #mpox requires continued surveillance, therapeutics and mitigating strategies. @GlobalVirusNews developed an article highlighting the prevention & treatment of mpox and the need for pandemic preparedness:

0

4

Siga Technologies

@SigaTech

5 months

Recently the White House administration launched the Global Health Security Strategy to prevent, detect, and respond to the spread of #infectiousdiseases in the U.S. and around the world. Learn more about the strategy in this @CSIS video:

The New U.S. Global Health Security Strategy | CSIS

Stephanie Psaki, U.S. Coordinator for Global Health Security, discusses the new U.S. Global Health Security Strategy.

www.csis.org

1

3

Siga Technologies

@SigaTech

10 months

We are honored to be named on @Deloitte Technology’s Fast 500 list, recognizing the most innovative and fastest-growing companies across North America. We thank our team & partners for their support in helping us become an industry leader across the #lifesciences sectors.

0

1

3

Siga Technologies

@SigaTech

8 months

At the World Economic Forum’s annual meeting in Switzerland, the @WHO emphasized the need to prepare for Disease X, an unknown pathogen that could emerge in the future and cause a pandemic. Read more:

World leaders are gathering to discuss Disease X. Here's what to know about the hypothetical...

World leaders and health experts gathered at the World Economic Forum's annual meeting in Davos to discuss a hypothetical disease X pandemic.

www.cbsnews.com

0

1

2

Siga Technologies

@SigaTech

3 years

SIGA is pleased to collaborate with Bioarchitech, an innovator of next-gen cancer immunotherapies. The pre-clinical studies will investigate TPOXX in combination with Bioarchitech’s proprietary vaccinia-based immunotherapy platform to see if TPOXX can enable delivery of larger

1

0

4

Siga Technologies

@SigaTech

11 months

#ICYMI as part of @AuthorityMgzine ’s interview series, our EVP and CMO @DrJayVarma explored the impact the COVID-19 pandemic had on the American #healthcare system and shared five key areas in need of improvement. Read the full interview:

3

2

4

Siga Technologies

@SigaTech

5 months

#Mpox cases have been on the rise since October, prompting efforts to prevent a summer surge like what was seen in 2022. In @thehill , our EVP and CMO @DrJayVarma shares his perspective on the increase of cases this year & the mpox outbreak in the DRC.

Elevated mpox cases spur efforts to avoid summer spread

Mpox cases have been elevated since October, with an average of roughly 200 monthly cases detected per month, spurring efforts to avoid a summer surge like what was seen in 2022. Recent numbe…

thehill.com

0

2

4

Siga Technologies

@SigaTech

3 months

We are excited to share that our CEO Diem Nguyen, Ph.D., M.B.A., is featured in the latest issue of the Darden Report magazine. As a proud alumna of @DardenMBA , Diem shares lessons on leading a team and cultivating the values essential for success:

Darden Leadership Lessons: ‘Stay Curious. Embrace the Journey. Never Stop Learning.’

In part one of our series on Darden leadership lessons, we checked in with Darden graduate Diem Nguyen (MBA ’01), CEO and director for SIGA Technologies Inc., a public, commercial-stage pharmaceuti...

news.darden.virginia.edu

0

1

4

Siga Technologies

@SigaTech

9 months

We are pleased to announce the appointment of Diem Nguyen, Ph.D., as our new CEO. We look forward to Dr. Nguyen’s leadership as we continue to develop antiviral therapies for #infectiousdiseases . See the full press release:

1

4

Siga Technologies

@SigaTech

1 year

Today we announced the signature by the European Commission’s DG HERA of a joint procurement framework contract under which 13 participating countries from the EU and EFTA can enhance #smallpox preparedness. See details in our press release:

0

2

3

Siga Technologies

@SigaTech

10 months

Recently @CEPIvaccines and @IQVIA have announced a strategic collaboration to enhance the world’s preparedness to rapidly conduct clinical research for biological countermeasures against emerging #infectiousdiseases . Learn more:

0

2

4

Siga Technologies

@SigaTech

11 months

Today at 4:30pm ET our management team will host a webcast and conference call to provide a business update. For more details, see our press release:

1

4

Siga Technologies

@SigaTech

11 months

Tomorrow at 10:45am ET, our EVP and CMO @DrJayVarma will join Former @NIAIDNews Director Anthony Fauci, MD, and the CEO of @nyphospital Steve Corwin, MD, for a panel discussion during New York-Presbyterian’s professional development retreat to discuss health leadership.

1

2

Siga Technologies

@SigaTech

2 years

Placebo-controlled clinical trials were initiated in 3 countries including the United States, United Kingdom and Democratic Republic of Congo to assess the safety and efficacy of TPOXX in participants with monkeypox. To read more please visit:

1

0

4

Siga Technologies

@SigaTech

10 months

Wishing you a happy and safe holiday season from all of us at SIGA!

0

1

2

Siga Technologies

@SigaTech

2 years

Existing harm reduction measures, at home-testing, and advancements in vaccines and treatments can help keep the monkeypox ( #mpox ) numbers as low as possible. However, we are not out of the woods just yet. Read the full article:

With New Daily Monkeypox Cases Now in Single Digits, Can We Declare the Mission Accomplished?

Monkeypox cases are slowing worldwide, but that does not mean clinical laboratories should not remain vigilant.

www.darkdaily.com

0

3

Siga Technologies

@SigaTech

17 days

In this @JAMA_current publication, @BSPH_CHS Senior Scholars @cmyeaton , @C_R_Watson , & @alexandraphelan discuss the resurgence of #mpox and emphasize the urgent need for countries to act swiftly in response to this international call for action:

The Resurgence of Mpox in Africa

This Viewpoint discusses the current mpox outbreak in Africa and why countries worldwide must urgently act to address it after the World Health Organization declared the event a Public Health...

jamanetwork.com

164

1

4

Siga Technologies

@SigaTech

8 months

#ICYMI in this @GoHealio “Life during COVID” series, industry leaders including our EVP and CMO, @DrJayVarma , share insights on the country’s preparedness for the next pandemic. See here:

1

2

4

Siga Technologies

@SigaTech

1 year

As #PRIDEMonth comes to an end, we remain committed to supporting the #LGBTQ + community and celebrating inclusivity and diversity.

1

3

Siga Technologies

@SigaTech

1 year

On #NationalAdministrativeProfessionalsDay , we would like to recognize all of our administrative professionals at SIGA. They are the backbone of the company and keep us moving and thriving every day. Thank you for your continued hard work and dedication!

0

4

Siga Technologies

@SigaTech

3 years

SIGA has received approval from @EMA_News for oral tecovirimat, the same SIGA formulation approved by the @US_FDA under the brand name TPOXX, for treatment of several orthopox viruses. This enables maximum access to tecovirimat across Europe, a key milestone for SIGA.

0

1

4

Siga Technologies

@SigaTech

2 years

SIGA today announced the declaration of a special dividend of $0.45 per share on the common stock of the Company. To join our earnings call, please visit our events page for details.

1

3

Siga Technologies

@SigaTech

8 months

Recently @syramadad joined @ProgressPotent1 to discuss her work focused on preparation, response, and recovery from #infectiousdisease outbreaks, with an emphasis on #healthcare and #publichealth bio preparedness. Watch the full video:

Dr. Syra Madad - Senior Director, System-wide Special Pathogens...

Dr. Syra Madad, DHSc, MSc, MCP is the Senior Director of the System-wide Special Pathogens Program, and Co-Principal Investigator at the Institute of Disaste...

www.youtube.com

0

3

Siga Technologies

@SigaTech

6 months

Last month marked the 4-year anniversary of @WHO declaring #COVID19 a global pandemic. Our EVP and CMO @DrJayVarma joined @fox5ny ’s @thisiscwelch to discuss where we are now and where we are headed. Watch the full clip:

1

3

Siga Technologies

@SigaTech

1 year

As exemplified by the #COVID19 and #mpox pandemics, major #infectiousdiseases and #epidemics have devastating impacts amongst individuals from minority ethnic groups, poorer socioeconomic backgrounds, and urban and rurally deprived locations.

1

0

2

Siga Technologies

@SigaTech

1 year

#DYK that #smallpox was responsible for 300 million deaths in the 20th century alone? Though smallpox has been eradicated, there is concern that it could be used against us. Learn how we are helping improve the preparedness for a potential smallpox event:

1

0

3

Siga Technologies

@SigaTech

1 year

To help you navigate #PRIDE2023 , @InterPride has developed a video assembling #publichealth experts @HHS_ASH and @dr_demetre to discuss precautions, prevention, vaccination, and the importance of destigmatizing #mpox this Pride season. Watch now:

Mpox & Pride: Know Before You Go!

Join us for a live stream featuring public health experts from the U.S. Department of Health and Human Services (HHS) and the White House National Mpox Respo...

www.youtube.com

4

1

3

Siga Technologies

@SigaTech

6 months

The @CGDev recently launched Season 2 of their Pandemic Proof podcast. In this episode, host @JavierHGuzmanC is joined by @JeanKaseya2 , Director General of @AfricaCDC , to discuss progress in enhancing outbreak preparedness and response in Africa. Tune in:

Pandemic Proof: A CGD Podcast

www.cgdev.org

0

3

Siga Technologies

@SigaTech

10 months

Our Executive Vice President and Chief Medical Officer, @DrJayVarma will be speaking at the @BioCommission meeting tomorrow to discuss #biodefense policy, procurement, and #publichealth . Learn more:

0

1

3

Siga Technologies

@SigaTech

18 days

As #mpox spreads rapidly, @Nature spoke with #infectiousdisease specialists to explore how this current emergency compares to the global outbreak of 2022 and how the clade Ib strain differs from the clade II strain that caused the earlier outbreak.

Mpox is spreading rapidly. Here are the questions researchers are racing to answer

Nature - Nature talks to infectious-disease specialists about whether vaccines will curb this outbreak and more.

www.nature.com

79

1

3

Siga Technologies

@SigaTech

2 months

Today @NIAIDNews announced topline results from a preliminary analysis of the PALM 007 clinical trial evaluating our investigational drug for the potential treatment of #mpox in the Democratic Republic of the Congo. See our press release:

2

1

3

Siga Technologies

@SigaTech

1 month

The #EPOXI trial has successfully launched its first sites in Germany and Belgium. This randomized controlled trial, led by UMCU and @Ecraid , will assess the efficacy and safety of our antiviral drug to treat adult #mpox patients.

5

2

3

Siga Technologies

@SigaTech

1 month

Following @WHO ’s #PHEIC declaration, @pharmaphorum spoke with our EVP and CMO @DrJayVarma about the clade 1b #mpox strain, available vaccines & treatments, the initial results from the PALM 007 study, and the criticality of pandemic preparedness. See here:

Not if, but when: Pandemic preparedness is crucial

pharmaphorum.com

11

2

3

Siga Technologies

@SigaTech

10 months

The Democratic Republic of Congo is currently experiencing the highest annual number of suspected #mpox cases reported. According to @WHO , the consequences could potentially be more severe than the worldwide outbreak last year. Learn more:

1

2

3

Siga Technologies

@SigaTech

11 months

The @WHO recently released a new #publichealth taxonomy for social listening on respiratory pathogens alongside other useful tools for infodemic management. Learn how this new tool can help WHO inform and guide their infodemic response:

0

2

3

Siga Technologies

@SigaTech

11 months

Today kicks off @BARDA ’s Industry Day! We look forward to collaborating with BARDA and other companies within the #healthsecurity space to discuss how we can better prepare for and respond to #publichealth emergencies in our ever-changing and unpredictable world. #BID2023

0

1

2

Siga Technologies

@SigaTech

2 years

The @CDCgov has released interim clinical considerations to help with decision-making in the management of severe manifestations of monkeypox ( #mpox ). Learn more:

Interim Clinical Treatment Considerations for Severe ..

This report describes interim clinical treatments for severe mpox developed following the evaluation of treatment data, cases, input from clinicians, and more.

www.cdc.gov

0

2

Siga Technologies

@SigaTech

3 months

Listen to insights from our Executive Vice President and Chief Medical Officer, @DrJayVarma , on the importance of consulting with your #healthcare provider to test for #infectiousdiseases such as #mpox , #herpes , #syphilis , and #chickenpox .

0

1

3

Siga Technologies

@SigaTech

1 year

As we continue to focus on providing solutions for unmet needs in the #healthsecurity market, we have cultivated key relationships with @BARDA and other organizations to enhance U.S national health preparedness against a potential threat. Learn more:

0

1

2

Siga Technologies

@SigaTech

4 years

We are excited that SIGA was featured in the January 2021 issue of NCT Magazine. This profile highlights SIGA as a leader in the health security market and our mission to address urgent recognized threats, such as bioterrorism: #SIGA #CBRN #NCT

0

1

3

Siga Technologies

@SigaTech

3 years

SIGA is excited to announce that Dr. Doug Grosenbach, Senior Director Poxvirus Research, will be presenting today at the @Intel_Sec CBRNe Summit Europe 2021 in Brno, Czech Republic on Smallpox Preparedness: Integrating TPOXX® into Response Planning.

0

1

3

Siga Technologies

@SigaTech

1 month

Recently @WHO launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of #mpox through coordinated global, regional, and national efforts. See here:

9

1

3

Siga Technologies

@SigaTech

1 year

From insightful discussions to forging new connections, #NCTEurope2023 was an enriching experience. We had the opportunity to connect with #CBRN professionals & share our focus to provide solutions within the #healthsecurity market. Learn more about SIGA:

0

2

Siga Technologies

@SigaTech

1 year

Recently @WHO released a technical brief providing key findings from a survey that provide valuable insights into the experiences and needs of communities affected by #mpox .

2

1

2

Siga Technologies

@SigaTech

2 years

In this @HIVgov interview, CDC’s @DrMerminCDC & Dr. Johnson Brooks discuss #monkeypox vaccines & treatment at #CROI2023 . Watch their conversation:

CDC’s Dr. Mermin and Dr. Brooks Share Mpox and HIV Prevention Highlights from CROI 2023

As the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) wound to a close this week, HIV.gov spoke with CDC s Dr. Jono Mermin and Dr. John B...

www.hiv.gov

0

3

Siga Technologies

@SigaTech

3 years

While smallpox has been eradicated worldwide, the bio-threat for a future outbreak continues to exist. That’s why SIGA is working with governments worldwide to ensure we’re properly prepared for the worst with safe and efficacious treatments.

0

3

Siga Technologies

@SigaTech

3 years

Siga CEO Phil Gomez will be speaking today at the NCT USA Conference, discussing the importance of advancing antiviral drug capabilities in preparation for any potential future endemic outbreaks.

0

1

3

Siga Technologies

@SigaTech

2 years

Our goal is to provide solutions for unmet needs in the #healthsecurity market that comprises medical countermeasures against #CBRN threats, as well as emerging #infectiousdiseases . Learn about our current efforts to enhance #pandemic preparedness:

0

3

Siga Technologies

@SigaTech

1 year

Let’s work together to promote #healthsecurity and increase health preparedness. We are seeking an experienced Director, Formulations & Process Development to join our Chemistry, Manufacturing and Controls team in Corvallis, Oregon. Learn more:

0

2

Siga Technologies

@SigaTech

1 year

Happy #IndependenceDay ! Today we celebrate freedom, unity, and the pursuit of a healthier future.

0

1

3

Siga Technologies

@SigaTech

11 months

In this @ProSyn article, Jose Manuel Barroso, former president of the European Commission and Chair of the Board of @gavi shares ways to improve upon the innovative mechanisms that emerged from the COVID-19 pandemic. Read the article:

0

1

2

Siga Technologies

@SigaTech

1 year

Congratulations to @dr_demetre , Director, CDC Division of HIV Prevention, and Deputy Coordinator, White House National Mpox Response, for being honored on @statnews ’ 2023 #STATUSList ! Learn about his work to mitigate the #mpox outbreak:

2023 STATUS List

STAT honors those that are driving life science forward with the 2023 STATUS List.

www.statnews.com

0

1

3

Siga Technologies

@SigaTech

4 years

SIGA announced that the Public Health Agency of Canada has awarded a contract to our partner, Meridian Medical Technologies, for the purchase of up to approximately $33 million of oral TPOXX within five years.

1

0

3

Siga Technologies

@SigaTech

3 months

As we celebrate #PrideMonth , we are dedicated to taking proactive steps to prevent and stop #mpox outbreaks, leveraging our expertise in #infectiousdiseases to make a difference in the lives of individuals worldwide. Learn more: #PRIDE2024

0

3

Siga Technologies

@SigaTech

4 months

If you are attending events such as #NYCPride or other #PRIDE2024 celebrations – have fun, remain vigilant, & prioritize safety measures to protect yourself and those around you from #mpox . Learn more from the @CDCgov :

0

3

Siga Technologies

@SigaTech

6 months

Today we join @WHO in recognizing #WorldHealthDay and championing the right of everyone, everywhere to have access to quality health services, education, and information. Learn more:

0

1

3

Siga Technologies

@SigaTech

1 month

The #COVID19 pandemic highlighted the need to upgrade systems for #infectiousdisease surveillance, forecasting, and modeling. Learn more in this @FrontPubHealth publication: @DrJayVarma

Frontiers | Infectious disease surveillance needs for the United States: lessons from Covid-19

The COVID-19 pandemic has highlighted the need to upgrade systems for infectious disease surveillance and forecasting and modeling of the spread of infection...

www.frontiersin.org

5

2

3

Siga Technologies

@SigaTech

5 months

Recently @WHO released a toolkit to aid country-level risk communication engagement practitioners, decision-makers, and partners in planning and implementing readiness and response activities for #mpox . See here:

0

1

2

Siga Technologies

@SigaTech

1 year

In an interview with @BBCNews , @BillGates said that #bioterrorism is the future threat we aren’t thinking enough about. Learn more about the importance of preparing against biological threats and the risks they pose to the public:

0

2

Siga Technologies

@SigaTech

1 year

Last month the @UN held an interactive multistakeholder hearing, supported by @WHO and @UHC2030 , to gather input on the dimensions of pandemic preparedness, prevention, and response. Read the full overview here:

0

2

Siga Technologies

@SigaTech

1 year

Staying safe from health risks including #mpox remains crucial and we continue to emphasize the importance of prioritizing #publichealth and wellbeing. Learn more about mpox prevention, symptoms, and resources:

0

1